S-1/A: Polomar Health Services Amends S-1 Filing

Polomar Health Services, Inc. filed an amendment to its S-1 registration statement, detailing offering expenses, indemnification policies, and recent unregistered stock issuances.

Summary

• Polomar Health Services, Inc. filed Amendment No. 2 to its S-1 registration statement for a proposed delayed or continuous public offering of securities.
• Estimated expenses for the issuance and distribution of securities total $30,000.00, including $860.83 for SEC registration, $10,000.00 for accounting, $15,000.00 for legal fees, and $4,139.17 for miscellaneous costs.
• The company's indemnification policy for directors and officers is detailed, aligning with Nevada Revised Statutes (NRS 78.7502 and 78.747) and its bylaws, providing for indemnification against expenses, liabilities, and losses.
• The SEC's opinion states that indemnification for liabilities arising under the Securities Act is against public policy and therefore unenforceable.
• On September 12, 2024, 10,000,000 shares of Common Stock were issued to CWR upon the full conversion of Series A Convertible Preferred Stock, exempt under Section 4(a)(2) of the Securities Act.
• As of September 30, 2024, approximately 207,414,147 shares of Common Stock were issued to former members of Polomar in connection with an acquisition, also exempt under Section 4(a)(2) of the Securities Act.
• The filing includes undertakings for future post-effective amendments to update the prospectus, reflect fundamental changes, or modify the distribution plan during the offering period.

Sentiment

Score: 5

Explanation: The filing is an administrative update for a future offering, detailing expenses, indemnification, and past share issuances. It does not contain financial performance or operational news that would typically drive positive or negative sentiment.

Positives

• The company has established comprehensive indemnification provisions for its directors and officers, which can help attract and retain qualified personnel.
• The company maintains director and officer liability insurance, providing an additional layer of protection for its leadership.
• The disclosure of recent unregistered share issuances indicates the completion of an acquisition and a preferred stock conversion, suggesting corporate activity and restructuring.

Negatives

• The SEC's stated opinion that indemnification for liabilities arising under the Securities Act is against public policy and unenforceable could expose directors and officers to personal liability in certain circumstances.
• The registration statement's effective date is delayed, requiring further amendments or SEC determination, indicating an ongoing process rather than immediate market access for the offering.

Risks

• Indemnification for liabilities arising under the Securities Act may be deemed unenforceable by the SEC, potentially increasing personal liability for directors and officers.
• The company is subject to ongoing regulatory compliance, including the requirement to file post-effective amendments to the registration statement to reflect material changes or update prospectus information.
• The proposed sale of securities on a delayed or continuous basis introduces uncertainty regarding the timing and terms of future capital raises.

Future Outlook

The proposed sale to the public will occur from time to time after the effective date of this registration statement. The company undertakes to file post-effective amendments to include required prospectuses, reflect fundamental changes, or update distribution plans, and to remove unsold securities from registration at the offering's termination.

Management Comments

• The company's bylaws and Nevada law provide for the fullest indemnification legally permissible for directors and officers against expenses, liability, and loss incurred in connection with their service.
• The company has the power to purchase and maintain insurance on behalf of its directors and officers, and currently does so.

Industry Context

This filing is an administrative amendment to a registration statement for a health services company. It primarily addresses regulatory compliance, corporate governance, and past capital activities, rather than providing specific insights into broader industry trends or competitive positioning within the health services sector.

Comparison to Industry Standards

• The indemnification provisions for directors and officers are standard for publicly traded companies, aligning with Nevada corporate law (NRS 78.7502, 78.747) which is comparable to other states' corporate statutes in providing protection for fiduciaries.
• The maintenance of director and officer liability insurance is a common practice across industries to mitigate risks for management and board members, consistent with global benchmarks for corporate governance.
• The SEC's stance on the unenforceability of indemnification for Securities Act liabilities is a consistent regulatory position across all industries, reflecting public policy concerns regarding investor protection.

Corporate Governance

Related Party Transactions

• On September 12, 2024, 10,000,000 shares of Common Stock were issued to CWR, the holder of 500,000 shares of Series A Convertible Preferred Stock, upon its full conversion.
• A Promissory Note and Loan Agreement with CWR 1, LLC was dated July 21, 2025.
• A Professional Services Agreement, dated March 21, 2024, was made by and among Trustfeed Corp. (now Polomar Health Services, Inc.), Terrence M. Tierney (President), and Profesco, Inc., with Addendum #3 dated July 29, 2025, and Addendum #4 dated October 29, 2025.
• A Promissory Note and Loan Agreement with Profesco Holdings, LLC was dated July 28, 2025, with a First Amendment dated October 31, 2025.
• An Executive Employment Agreement, effective September 15, 2025, was made between the company and Terrence M. Tierney.

Stakeholder Impact

• **Shareholders**: Potential future dilution from the proposed public offering. The indemnification policies and D&O insurance may reduce the risk of personal liability for management, but the SEC's stance on Securities Act indemnification could shift certain liabilities back to the company or its fiduciaries, indirectly affecting shareholder value.
• **Directors and Officers**: Benefit from comprehensive indemnification provisions and D&O insurance, reducing personal financial exposure to legal actions. However, the SEC's position on Securities Act liabilities means certain indemnification claims may be unenforceable, requiring careful consideration of personal risk.
• **Potential Investors**: The S-1/A filing provides transparency regarding the company's intent for a future public offering, its corporate governance structure, and past unregistered share issuances, which are crucial for due diligence.

Next Steps

• File a further amendment to specifically state that the registration statement shall become effective, or await the SEC's determination of an effective date.
• During any period in which offers or sales are being made, file post-effective amendments to include any required prospectus, reflect fundamental changes, or update the plan of distribution.
• Remove any unsold securities from registration by means of a post-effective amendment at the termination of the offering.
• If a claim for indemnification for liabilities arising under the Securities Act is asserted, and not settled by controlling precedent, submit the question of public policy enforceability to a court of appropriate jurisdiction.

Key Dates

Keywords

Polomar Health Services, S-1/A, SEC filing, registration statement, public offering, indemnification, unregistered securities, corporate governance, health services, capital raise